| [1] |
Sideri M, Jones RW, Wilkinson EJ, et al. Squamous vulvar intraepithelial neoplasia:2004 modified terminology, ISSVD Vulvar Oncology Subcommittee[J]. J Reprod Med, 2005, 50:807-810.
|
| [2] |
van de Nieuwenhof HP, Massuger LF, van der Avoort IA, et al. Vulvar squamous cell carcinoma development after diagnosis of VIN increases with age[J]. Eur J Cancer, 2009, 45:851-856.
|
| [3] |
Akerman G, Dussour C, Haddad B, et al.Epidemiology of vulvar intra-epithelial neoplasias[J]. Gynecol Obstet Fertil, 2007, 35(12):1251-1256.
|
| [4] |
Jamieson DJ, Paramsothy P, Cu-Uvin S, et al.Group HIVERS. Vulvar, vaginal, and perianal intraepithelial neoplasia in women with or at risk for human immunodeficiency virus[J]. Obstet Gynecol, 2006, 107:1023-1028.
|
| [5] |
Khan AM, Freeman-Wang T, Pisal N, et al. Smoking and multicentric vulval intraepithelial neoplasia[J]. J Obstet Gynaecol, 2009, 29:123-125.
|
| [6] |
van Seters M, Beckmann I, Heijmans-Antonissen C, et al. Disturbed patterns of immunocompetent cells in usual-type vulvar intraepithelial neoplasia[J]. Cancer Res, 2008, 68:6617-6622.
|
| [7] |
Bourgault Villada I, Moyal Barracco M, Ziol M, et al. Spontaneous regression of grade 3 vulvar intraepithelial neoplasia associated with human papillomavirus-16-specific CD4(＋)and CD8(＋)T-cell responses[J]. Cancer Res, 2004, 64:8761-8766.
|
| [8] |
Hart WR. Vulvar intraepithelial neoplasia:Historical aspects and current status[J]. Int J Gynecol Pathol, 2001, 20(1):16-30.
|
| [9] |
Hoevenaars BM, van der Avoort IA, de Wilde PC, et al.A panel of p16(INK4A), MIB1 and p53 proteins can distinguish between the 2 pathways leading to vulvar squamous cell carcinoma[J]. Int J Cancer, 2008, 123(12):2767-2773.
|
| [10] |
Mathiesen O, Buus SK, Cramers M. Topical imiquimod can reverse vulvar intraepithelial neoplasia:A randomised, double-blinded study[J]. Gynecol Oncol, 2007, 107(2):219-222.
|
| [11] |
van Seters M, van Beurden M, ten Kate FJW, et al. Treatment of vulvar intraepithelial neoplasia with topical imiquimod[J]. New Engl J Med, 2008, 358:1465-1473.
|
| [12] |
Terlou A, van Seters M, Ewing PC, et al. Treatment of vulvar intraepithelial neoplasia with topical imiquimod:Seven years median follow-up of a randomized clinical trial[J]. Gynecol Oncol, 2011, 121:157-162.
|
| [13] |
Kenter GG, Welters MJ, Valentijn AR. Vaccination against HPV216 oncoproteins for vulvar intraep ithelial neop lasia[J]. N Engl J Med, 2009, 361 (19):18382-18471.
|
| [14] |
Markowitz LE. HPV vaccines prophylactic, not therapeutic[J]. JAMA, 2007, 298(7):805-806.
|
| [15] |
Tristram A, Fiander A. Clinical responses to cidofovir applied topically to women with high grade vulval intraepithelial neoplasia[J]. Gynecol Oncol, 2005, 99(3):652-625.
|
| [16] |
van Seters M, van Beurden M, de Craen AJ. Is the assumed natural history of vulvar intraepithelial neoplasia Ⅲ based on enough evidence? A systematic review of 3322 published patients[J]. Gynecol Oncol, 2005, 97(2):645-651.
|
| [17] |
Soergel P, Hillemanns P. Photodynamic therapy for intraepithelial neoplasia of the lower genital tract[J]. Photodiagnosis Photodyn Ther, 2010, 7:10-14.
|
| [18] |
Jones RW, Rowan DM, Stewart AW. Vulvar intraepithelial neoplasia:Aspects of the natural history and outcome in 405 women[J]. Obstet Gynecol, 2005, 106(6):1319-1326.
|
| [19] |
Eva LJ, Ganesan R, Chan KK, et al. Vulval squamous cell carcinoma occurring on a background of differentiated vulval intraepithelial neoplasia is more likely to recur:A review of 154 cases[J]. J Reprod Med, 2008, 53:397-401.
|
| [20] |
Paavonen J, Jenkins D, Bosch FX, et al. Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women:An interim analysis of a phase Ⅲ double-blind, randomised controlled trial[J]. Lancet, 2007, 369(9580):2161-2170.
|